More On

Supreme Court hears gene patentability arguments

The court will decide whether two genetic sequences linked to breast and ovarian cancer constitute unpatentable “natural law”

The Supreme Court on Monday will hear oral arguments from a group of doctors and patients who contend that patents on human genes are hindering medical research.

Plaintiffs in the suit, who are represented by the American Civil Liberties Union and the Public Patent Foundation, say that Myriad Genetics Inc. should not be allowed to hold patents on two genetic sequences that are linked to a higher hereditary risk of ovarian and breast cancer.

Alanna Byrne

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.